{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:47:01Z","timestamp":1787068021478,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772797"],"award-info":[{"award-number":["81772797"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Education Commission\u2014Gaofeng Clinical Medicine Grant Support","award":["20172007"],"award-info":[{"award-number":["20172007"]}]},{"name":"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine-Guangci Excellent Youth Training Program","award":["GCQN-2017-A18"],"award-info":[{"award-number":["GCQN-2017-A18"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10549-020-05842-9","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T16:02:36Z","timestamp":1596297756000},"page":"193-202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Axillary lymph node and non-sentinel lymph node metastasis among the ACOSOG Z0011 eligible breast cancer patients with invasive ductal, invasive lobular, or other histological special types: a multi-institutional retrospective analysis"],"prefix":"10.1007","volume":"184","author":[{"given":"Weiqi","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3286-0035","authenticated-orcid":false,"given":"Xiaosong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunwei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,1]]},"reference":[{"issue":"6","key":"5842_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305(6):569\u2013575. https:\/\/doi.org\/10.1001\/jama.2011.90","journal-title":"JAMA"},{"issue":"3","key":"5842_CR2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/sla.0000000000001863","volume":"264","author":"AE Giuliano","year":"2016","unstructured":"Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Morrow M, Hunt KK (2016) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trial. Ann Surg 264(3):413\u2013420. https:\/\/doi.org\/10.1097\/sla.0000000000001863","journal-title":"Ann Surg"},{"issue":"10","key":"5842_CR3","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M (2017) Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA 318(10):918\u2013926. https:\/\/doi.org\/10.1001\/jama.2017.11470","journal-title":"JAMA"},{"issue":"1","key":"5842_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1245\/s10434-013-3200-6","volume":"21","author":"LT Dengel","year":"2014","unstructured":"Dengel LT, Van Zee KJ, King TA, Stempel M, Cody HS, El-Tamer M, Gemignani ML, Sclafani LM, Sacchini VS, Heerdt AS, Plitas G, Junqueira M, Capko D, Patil S, Morrow M (2014) Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy. Ann Surg Oncol 21(1):22\u201327. https:\/\/doi.org\/10.1245\/s10434-013-3200-6","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"5842_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10549-018-5009-2","volume":"173","author":"A Hennigs","year":"2019","unstructured":"Hennigs A, K\u00f6pke M, Fei\u00dft M, Riedel F, Rezai M, Nitz U, Moderow M, Golatta M, Sohn C, Schneeweiss A, Heil J (2019) Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice? Breast Cancer Res Treat 173(2):429\u2013438. https:\/\/doi.org\/10.1007\/s10549-018-5009-2","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"5842_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10549-019-05327-4","volume":"177","author":"F Riedel","year":"2019","unstructured":"Riedel F, Heil J, Fei\u00dft M, Rezai M, Moderow M, Sohn C, Sch\u00fctz F, Golatta M, Hennigs A (2019) Non-sentinel axillary tumor burden applying the ACOSOG Z0011 eligibility criteria to a large routine cohort. Breast Cancer Res Treat 177(2):457\u2013467. https:\/\/doi.org\/10.1007\/s10549-019-05327-4","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"5842_CR7","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.ejca.2007.04.004","volume":"43","author":"G Cserni","year":"2007","unstructured":"Cserni G, Bianchi S, Vezzosi V, Arisio R, Bori R, Peterse JL, Sapino A, Drijkoningen M, Kulka J, Eusebi V, Foschini MP, Bellocq J-P, Marin C, Thorstenson S, Amendoeira I, Reiner-Concin A, Decker T (2007) Sentinel lymph node biopsy and non-sentinel node involvement in special type breast carcinomas with a good prognosis. Eur J Cancer 43(9):1407\u20131414. https:\/\/doi.org\/10.1016\/j.ejca.2007.04.004","journal-title":"Eur J Cancer"},{"issue":"1","key":"5842_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1186\/s13104-018-3623-z","volume":"11","author":"AA Hashmi","year":"2018","unstructured":"Hashmi AA, Aijaz S, Mahboob R, Khan SM, Irfan M, Iftikhar N, Nisar M, Siddiqui M, Edhi MM, Faridi N, Khan A (2018) Clinicopathologic features of invasive metaplastic and micropapillary breast carcinoma: comparison with invasive ductal carcinoma of breast. BMC Res Notes 11(1):531. https:\/\/doi.org\/10.1186\/s13104-018-3623-z","journal-title":"BMC Res Notes"},{"issue":"2","key":"5842_CR9","doi-asserted-by":"publisher","first-page":"e89778","DOI":"10.1371\/journal.pone.0089778","volume":"9","author":"J Wang","year":"2014","unstructured":"Wang J, Mittendorf EA, Sahin AA, Yi M, Caudle A, Hunt KK, Wu Y (2014) Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: a retrospective study of the surveillance, epidemiology and end results (SEER) database. PLoS ONE 9(2):e89778. https:\/\/doi.org\/10.1371\/journal.pone.0089778","journal-title":"PLoS ONE"},{"issue":"10","key":"5842_CR10","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1245\/s10434-015-4756-0","volume":"22","author":"A Roberts","year":"2015","unstructured":"Roberts A, Nofech-Mozes S, Youngson B, McCready DR, Al-Assi M, Ramkumar S, Cil T (2015) The importance of applying ACOSOG Z0011 criteria in the axillary management of invasive lobular carcinoma: a multi-institutional cohort study. Ann Surg Oncol 22(10):3397\u20133401. https:\/\/doi.org\/10.1245\/s10434-015-4756-0","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"5842_CR11","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s12282-018-0852-x","volume":"25","author":"Y Adachi","year":"2018","unstructured":"Adachi Y, Sawaki M, Hattori M, Yoshimura A, Gondo N, Kotani H, Iwase M, Kataoka A, Onishi S, Sugino K, Terada M, Horisawa N, Mori M, Oze I, Iwata H (2018) Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma. Breast Cancer 25(5):560\u2013565. https:\/\/doi.org\/10.1007\/s12282-018-0852-x","journal-title":"Breast Cancer"},{"issue":"9","key":"5842_CR12","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","volume":"24","author":"A Goldhirsch","year":"2013","unstructured":"Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, Senn HJ (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 24(9):2206\u20132223. https:\/\/doi.org\/10.1093\/annonc\/mdt303","journal-title":"Ann Oncol"},{"issue":"5","key":"5842_CR13","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/annonc\/mdv106","volume":"26","author":"S Gourgou-Bourgade","year":"2015","unstructured":"Gourgou-Bourgade S, Cameron D, Poortmans P, Asselain B, Azria D, Cardoso F, A'Hern R, Bliss J, Bogaerts J, Bonnefoi H, Brain E, Cardoso MJ, Chibaudel B, Coleman R, Cufer T, Dal Lago L, Dalenc F, De Azambuja E, Debled M, Delaloge S, Filleron T, Gligorov J, Gutowski M, Jacot W, Kirkove C, MacGrogan G, Michiels S, Negreiros I, Offersen BV, Penault Llorca F, Pruneri G, Roche H, Russell NS, Schmitt F, Servent V, Thurlimann B, Untch M, van der Hage JA, van Tienhoven G, Wildiers H, Yarnold J, Bonnetain F, Mathoulin-Pelissier S, Bellera C, Dabakuyo-Yonli TS (2015) Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)dagger. Ann Oncol 26(5):873\u2013879. https:\/\/doi.org\/10.1093\/annonc\/mdv106","journal-title":"Ann Oncol"},{"issue":"3","key":"5842_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.adro.2018.03.004","volume":"3","author":"BJ Gebhardt","year":"2018","unstructured":"Gebhardt BJ, Thomas J, Horne ZD, Champ CE, Farrugia DJ, Diego E, Ahrendt GM, Beriwal S (2018) Is completion axillary lymph node dissection necessary in patients who are underrepresented in the ACOSOG Z0011 trial? Adv Radiat Oncol 3(3):258\u2013264. https:\/\/doi.org\/10.1016\/j.adro.2018.03.004","journal-title":"Adv Radiat Oncol"},{"issue":"4","key":"5842_CR15","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/j.clbc.2016.03.007","volume":"16","author":"W Truin","year":"2016","unstructured":"Truin W, Roumen RM, Siesling S, van der Heiden-van der Loo M, Lobbezoo DJ, Tjan-Heijnen VC, Voogd AC (2016) Sentinel lymph node biopsy and isolated tumor cells in invasive lobular versus ductal breast cancer. Clin Breast Cancer 16(4):e75\u201382. https:\/\/doi.org\/10.1016\/j.clbc.2016.03.007","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"5842_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5152\/tjbh.2016.2929","volume":"12","author":"M Sol\u00e0","year":"2016","unstructured":"Sol\u00e0 M, Recaj M, Castell\u00e0 E, Puig P, Gubern JM, Julian JF, Fraile M (2016) Sentinel node biopsy in special histologic types of invasive breast cancer. J Breast Health 12(2):78\u201382. https:\/\/doi.org\/10.5152\/tjbh.2016.2929","journal-title":"J Breast Health"},{"issue":"13","key":"5842_CR17","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1245\/s10434-019-07901-y","volume":"26","author":"BM Raber","year":"2019","unstructured":"Raber BM, Lin H, Shen Y, Shaitelman SF, Bedrosian I (2019) Trends in regional nodal management of breast cancer patients with low nodal burden. Ann Surg Oncol 26(13):4346\u20134354. https:\/\/doi.org\/10.1245\/s10434-019-07901-y","journal-title":"Ann Surg Oncol"},{"key":"5842_CR18","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1200\/jco.2013.54.1177","volume":"32","author":"GH Lyman","year":"2014","unstructured":"Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL, Benson AB III, Bosserman LD, Burstein HJ, Cody H 3rd, Hayman J, Perkins CL, Podoloff DA, Giuliano AE (2014) Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 32:1365\u20131383. https:\/\/doi.org\/10.1200\/jco.2013.54.1177","journal-title":"J Clin Oncol"},{"issue":"1","key":"5842_CR19","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1186\/s12885-019-5823-x","volume":"19","author":"S Majid","year":"2019","unstructured":"Majid S, Ryd\u00e9n L, Manjer J (2019) Determinants for non-sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 602 consecutive patients with sentinel node metastases. BMC Cancer 19(1):626\u2013626. https:\/\/doi.org\/10.1186\/s12885-019-5823-x","journal-title":"BMC Cancer"},{"issue":"10","key":"5842_CR20","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1245\/s10434-019-07536-z","volume":"26","author":"A Mamtani","year":"2019","unstructured":"Mamtani A, Zabor EC, Stempel M, Morrow M (2019) Lobular histology does not predict the need for axillary dissection among ACOSOG Z0011-eligible breast cancers. Ann Surg Oncol 26(10):3269\u20133274. https:\/\/doi.org\/10.1245\/s10434-019-07536-z","journal-title":"Ann Surg Oncol"},{"key":"5842_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-020-05565-x","author":"SP Corona","year":"2020","unstructured":"Corona SP, Bortul M, Scomersi S, Bigal C, Bottin C, Zanconati F, Fox SB, Giudici F, Generali D (2020) Management of the axilla in breast cancer: outcome analysis in a series of ductal versus lobular invasive cancers. Breast Cancer Res Treat. https:\/\/doi.org\/10.1007\/s10549-020-05565-x","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05842-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-020-05842-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05842-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T19:50:34Z","timestamp":1627761034000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-020-05842-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["5842"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-05842-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,1]]},"assertion":[{"value":"16 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The present study was reviewed and approved by independent ethical committees of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}